{"id":3566,"date":"2023-11-15T00:00:12","date_gmt":"2023-11-14T15:00:12","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/international_care\/ncc_today\/3566"},"modified":"2025-09-18T15:21:24","modified_gmt":"2025-09-18T06:21:24","slug":"%e6%9c%80%e5%85%88%e7%ab%af%e3%81%ae%e8%82%ba%e7%99%8c%e6%b2%bb%e7%99%82%e2%80%95%e5%9b%bd%e7%ab%8b%e3%81%8c%e3%82%93%e7%a0%94%e7%a9%b6%e3%82%bb%e3%83%b3%e3%82%bf%e3%83%bc%e4%b8%ad%e5%a4%ae%e7%97%85","status":"publish","type":"imcs_blog","link":"https:\/\/atlas.ncc.go.jp\/en\/international_care\/ncc_today\/3566","title":{"rendered":"Lung Cancer Treatment at the National Cancer Center Hospital"},"template":"","class_list":["post-3566","imcs_blog","type-imcs_blog","status-publish","hentry","en-US"],"acf":{"title_en":"Lung Cancer Treatment at the National Cancer Center Hospital","from":{"jp":"Yusuke Okuma","en":"Yusuke Okuma"},"content":{"jp":"<p style=\"text-align: right;\">2023\/11\/15<\/p>\r\n<p><span>Lung cancer treatment has been transformed in recent years by advances in personalized molecular targeted therapy and immunotherapy. National Cancer Center Hospital is at the forefront of incorporating these state-of-the-art treatments, aiming to improve survival rates for lung cancer patients. Particularly in non-small cell lung cancer treatment, personalized medicine\u2014identifying genetic alterations and selecting the most effective and optimal chemotherapy for those alterations\u2014is gaining prominence. Also, we can provide treatment including clinical trials by way of the early introduction of new treatments, offering hope to lung cancer patients. Our specialists are committed to providing individualized treatment plans and aspire to deliver the highest standard of care for patients having thoracic malignances such as lung cancer, mesothelioma, and thymic malignancies.<\/span><\/p>","en":"<p style=\"text-align: right;\">2023\/11\/15<\/p>\r\n<p><span>Lung cancer treatment has been transformed in recent years by advances in personalized molecular targeted therapy and immunotherapy. National Cancer Center Hospital is at the forefront of incorporating these state-of-the-art treatments, aiming to improve survival rates for lung cancer patients. Particularly in non-small cell lung cancer treatment, personalized medicine\u2014identifying genetic alterations and selecting the most effective and optimal chemotherapy for those alterations\u2014is gaining prominence. Also, we can provide treatment including clinical trials by way of the early introduction of new treatments, offering hope to lung cancer patients. Our specialists are committed to providing individualized treatment plans and aspire to deliver the highest standard of care for patients having thoracic malignances such as lung cancer, mesothelioma, and thymic malignancies.<\/span><\/p>"},"thumbnail":2276,"show_in_detail":true,"show_in_topics":["1"],"show_in_imcs_dept":["9"]},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/imcs_blog\/3566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/imcs_blog"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/imcs_blog"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}